Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

1 in non-Hodgkin's lymphoma. Under a strategic alliance established in 2001, Cytokinetics and GlaxoSmithKline (GSK) are conducting research and development activities focused on the potential treatment of cancer. GSK has obtained an option for the joint development and commercialization of ispinesib and SB-743921, exercisable during a defined period. Cytokinetics and GSK are conducting collaborative research activities directed to the mitotic kinesin centromere-associated protein E (CENP-E). GSK-923295, a CENP-E inhibitor, is being developed under the strategic alliance by GSK. GSK is expected to begin clinical trials with GSK-923295 in 2007. All of these drug candidates have arisen from Cytokinetics research activities and are directed towards the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. Cytokinetics focus on the cytoskeleton enables it to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, and cardiovascular disease. Additional information about Cytokinetics can be obtained at www.cytokinetics.com.

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the ?Act?). Cytokinetics disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, statements relating to the expected initiation, timing, conduct, scope and results of Cytokinetics and its partners research and development programs, including initiation of clinical trials; anticipated dates of release of data from clinical trials; the potential benefits of Cytokinetics drug candidates and potential drug candidates, including the benefits of mitotic kinesin i
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:3/31/2015)... Mauna Kea Technologies (Euronext: MKEA, ... platform, today announced the set-up of an optical biopsy ... The CHU de Grenoble is now the first hospital ... its gastroenterology, interventional pulmonology and urology patients an innovative ... care thanks to the endomicroscopy technology developed by Mauna ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and Markets ... of the "Intraoperative Imaging Market by Type (Intraoperative ... 2019" report to their offering. The ... a CAGR of 3.5% from 2014 to 2019 ... due to a number of forces that favor this ...
(Date:3/31/2015)... 2015 According to a ... Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, ... Hood, Centrifuge) - Global Forecast to 2019", published ... Instrumentation Market is expected to reach $48.84 Billion ... to 2019. Browse   9 ...
Breaking Medicine Technology:Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 2Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 3Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market 2015-2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5
(Date:3/31/2015)... (PRWEB) March 31, 2015 BESLER ... paper entitled, “The Value of an Independent Cost ... to play a critical role in the determination ... With the appropriate understanding and review, this report ... and strategic planning. , This white paper discusses:, ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 With intravenous ... vein using a catheter. Patients, typically, are prescribed IV ... that oral medications are no longer effective. Illness ... needed to help with electrolyte imbalances. Infusion therapy ... illness. In addition to treating dehydration, IV infusion therapy ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Williams ... a repair visit when their home comfort is ... and make the visit fit into the customer’s ... provide fast, quality repair at requested times. ... and commercial customers in the Indianapolis area can ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 DataEntryOutsourced ... professional team of data entry experts to handle the ... tasked with managing a complex nutritional scoring system for ... a free trial of their nutrition scale data entry ... — "A Case Study on U.S. Food Nutrition Scale ...
(Date:3/31/2015)... The status of more than 1,000 ... a Case Management Conference scheduled to be held in ... on April 21st. According to court documents, the jurisdiction ... for Mirena lawsuits filed on behalf of women who ... complications related to the birth control device. (In re: ...
Breaking Medicine News(10 mins):Health News:Intravenous Infusion Therapy Now Available at Urgent Care of Texas Centers; Hospital-Level Care in an Outpatient Setting. 2Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:DEO Announces a Team of Dedicated Data Entry Operators for Nutrition Score Data Entry 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 3
... ,mild, smokers in Western countries continue falsely to believe ... others. In fact, all conventional brands of cigarette ... ,mild, and ,low-tar, brands. A study published today ... smokers from Australia, Canada, the United Kingdom and the ...
... Amanda Gardner HealthDay Reporter , MONDAY, April 11 ... primary care doctors often choose a different option than they ... In fact, physicians who were surveyed in the research more ... to have long-term repercussions, such as paralysis, than to die. ...
... An Oregon Health & Science University researcher has co-authored ... rejection in organ transplant patients helped treat a rare lung ... and, until now, no known treatment. The clinical trial ... randomized, controlled study designed to develop a therapy for the ...
... News) -- Long-term use of antibiotics to treat acne ... the medications, a new study finds. The finding ... use of antibiotics has been credited with encouraging antibiotic ... of Pennsylvania School of Medicine assessed the prevalence of ...
... (QB3) has entered into a collaboration with Deloitte to ... innovation into a driver for jobs, companies and improved ... tax and financial advisory services, will provide its services ... ecosystem," bringing together the four pillars of the bioscience ...
... can reveal your risk of a future heart attack, and ... more detail thanks to a new technique which could eventually ... reveals a thesis from the University of Gothenburg, Sweden. ... risk of future heart disease, and it is therefore important ...
Cached Medicine News:Health News:Smokers believe 'silver', 'gold' and 'slim' cigarettes are less harmful 2Health News:Doctors Often Wouldn't Follow Their Own Advice: Study 2Health News:Doctors Often Wouldn't Follow Their Own Advice: Study 3Health News:OHSU expert co-authors study finding treatment for rare lung disease 2Health News:Acne Antibiotics Not Linked to Drug Resistance 2Health News:QB3, Deloitte collaborate to drive California bioscience innovation 2Health News:New potential atherosclerosis risk marker discovered 2
... Orion incorporates superior optics in a durable ... fully adjustable headband, made of white molded ... the brow, directing the spot along your ... the headband position the cable diagonally over ...
... of intelligent Pulse Oximeter technology. New ... over 7 years by a dedicated ... non-invasive oxygen saturation monitoring. The combination ... sophisticated saturation sensor designs using our ...
... the Novametrix' family of capnography products. Along ... are the only handheld, mainstream capnographs available ... patient's airway condition and ventilatory status. Based ... capnographs, we miniaturized the size, not the ...
A software program for simple, efficient pulse oximetry analysis, which enables easy viewing, analysis and report generation for pulse rate and SpO 2 ....
Medicine Products: